Loading clinical trials...

Addition of Acetaminophen in Standard PDA Management | Clinical Trials | Clareo Health

WITHDRAWNPhase 2NCT04026464

Addition of Acetaminophen in Standard PDA Management

Patent ductus arteriosus is a common morbidity in preterm infants and management of PDA varies among neonatologist. The investigators are conducting a randomized controlled trial to determine the rate...

Lead sponsor: University of Florida•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

PDA for Kidneys Study

NCT06658496 · Patent Ductus Arteriosus, Congenital Heart Disease

RECRUITINGPhase 2

Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT

NCT07143201 · Patent Ductus Arteriosus, Preterm

RECRUITINGEARLY Phase 1

The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease

NCT06298344 · Congenital Heart Disease, Thiamine Deficiency, and more

Active Not RecruitingNA

PREEMIE: Study for Treatment of PDA in Premature Infants

NCT06587282 · Patent Ductus Arteriosus (PDA)

Active Not RecruitingPhase 3

Management of the PDA Trial

NCT03456336 · Infant, Premature, Patent Ductus Arteriosus, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 24, 2021Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE2

Enrollment—

Start dateApr 2021

Last updatedJun 24, 2021

Condition

Patent Ductus Arteriosus

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions